Krilogy Financial LLC Novo Nordisk A S Transaction History

Krilogy Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$132.34 - $159.14 $181,438 - $218,180	1,371 New	1,371 $218,000
Q4 2018 Feb 14, 2019	SELL	$41.54 - $47.25 $21,808 - $24,806	-525 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$46.76 - $51.24 $24,549 - $26,901	525 New	525 $25,000
Q2 2018 Aug 15, 2018	SELL	$44.29 - $50.42 $23,252 - $26,470	-525 Closed	0 $0
Q2 2017 Aug 15, 2017	BUY	N/A	525	525 $23,000

1,955

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $252B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Krilogy Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Krilogy Financial LLC with notifications on news.